1. Home
  2. TSBX vs ULY Comparison

TSBX vs ULY Comparison

Compare TSBX & ULY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSBX
  • ULY
  • Stock Information
  • Founded
  • TSBX 2015
  • ULY 2013
  • Country
  • TSBX United States
  • ULY United States
  • Employees
  • TSBX N/A
  • ULY N/A
  • Industry
  • TSBX
  • ULY
  • Sector
  • TSBX
  • ULY
  • Exchange
  • TSBX Nasdaq
  • ULY Nasdaq
  • Market Cap
  • TSBX 7.7M
  • ULY 7.4M
  • IPO Year
  • TSBX 2023
  • ULY N/A
  • Fundamental
  • Price
  • TSBX $0.36
  • ULY $4.67
  • Analyst Decision
  • TSBX Buy
  • ULY Strong Buy
  • Analyst Count
  • TSBX 3
  • ULY 1
  • Target Price
  • TSBX $4.75
  • ULY $12.00
  • AVG Volume (30 Days)
  • TSBX 625.8K
  • ULY 33.1K
  • Earning Date
  • TSBX 05-08-2025
  • ULY 05-13-2025
  • Dividend Yield
  • TSBX N/A
  • ULY N/A
  • EPS Growth
  • TSBX N/A
  • ULY N/A
  • EPS
  • TSBX N/A
  • ULY N/A
  • Revenue
  • TSBX N/A
  • ULY $134,085,000.00
  • Revenue This Year
  • TSBX N/A
  • ULY N/A
  • Revenue Next Year
  • TSBX N/A
  • ULY $23.08
  • P/E Ratio
  • TSBX N/A
  • ULY N/A
  • Revenue Growth
  • TSBX N/A
  • ULY N/A
  • 52 Week Low
  • TSBX $0.29
  • ULY $2.99
  • 52 Week High
  • TSBX $3.05
  • ULY $23.52
  • Technical
  • Relative Strength Index (RSI)
  • TSBX 56.52
  • ULY 35.73
  • Support Level
  • TSBX $0.32
  • ULY $5.01
  • Resistance Level
  • TSBX $0.38
  • ULY $5.77
  • Average True Range (ATR)
  • TSBX 0.03
  • ULY 0.56
  • MACD
  • TSBX 0.00
  • ULY -0.29
  • Stochastic Oscillator
  • TSBX 78.89
  • ULY 0.23

About TSBX Turnstone Biologics Corp.

Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.

About ULY Urgent.ly Inc.

Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and to long wait times. Urgently offers an alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.

Share on Social Networks: